न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - pazopanib hydrochloride 216.7mg equivalent to 200 mg pazopanib base;  ;   - film coated tablet - 200 mg - active: pazopanib hydrochloride 216.7mg equivalent to 200 mg pazopanib base     excipient: magnesium stearate microcrystalline cellulose opadry pink ys-1-14762-a povidone sodium starch glycolate - votrient is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (rcc).

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - pazopanib hydrochloride 433.4mg equivalent to 400 mg pazopanib base;  ;   - film coated tablet - 400 mg - active: pazopanib hydrochloride 433.4mg equivalent to 400 mg pazopanib base     excipient: magnesium stearate microcrystalline cellulose opadry white ys-1-7706-g povidone sodium starch glycolate - votrient is indicated for the treatment of advanced and/or metastatic renal cell carcinoma (rcc).

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - bazedoxifene acetate 22.56mg equivalent to 20mg bazedoxifene - in tablet subcoat;  ; conjugated estrogens 0.45mg (10.4895 mg conjugated estrogens (ce) dessication with lactose (containing 4.29% ce) - in tablet core);   - modified release tablet - 0.45mg/20mg - active: bazedoxifene acetate 22.56mg equivalent to 20mg bazedoxifene - in tablet subcoat   conjugated estrogens 0.45mg (10.4895 mg conjugated estrogens (ce) dessication with lactose (containing 4.29% ce) - in tablet core)   excipient: ascorbic acid hyprolose hypromellose     isopropyl alcohol lactose monohydrate macrogol 400 magnesium stearate microcrystalline cellulose   opacode black ns-78-17821 opadry pink 03b14899 opaglos clear 98z19173 purified water     sucrose   sucrose palmitate - duavive is indicated for treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not appropriate. the experience treating women older than 65 years is limited.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - powder for injection - 1 mg - active: indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - indomethacin is indicated for the closure of patent ductus arteriosus in premature babies. clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. indomethacin should only be used in a hospital under supervision of a specialist neonatologist.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

viatris limited - indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - powder for injection - 1 mg - active: indometacin sodium trihydrate 1.061mg equivalent to indomethacin 1 mg - indomethacin is indicated for the closure of patent ductus arteriosus in premature babies. clear-cut clinical evidence of a haemodynamically significant patent ductus arteriosus should be present, such as respiratory distress, a continuous murmur, a hyperactive precordium, cardiomegaly and pulmonary plethora on chest x-ray. indomethacin should only be used in a hospital under supervision of a specialist neonatologist.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - sunitinib malate 50.1mg equivalent to 37.5mg sunitinib;   - capsule - 37.5 mg - active: sunitinib malate 50.1mg equivalent to 37.5mg sunitinib   excipient: croscarmellose sodium gelatin ink iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - sutent is indicated for the treatment of advanced renal cell carcinoma.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

te arai biofarma limited - aspirin 100mg (2 x 50mg);  ; atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin));  ; ramipril 10mg;   - combination capsule - 100mg/20mg/10mg - active: aspirin 100mg (2 x 50mg)   excipient: microcrystalline cellulose opadry white oy-b-28920 amb purified talc sodium starch glycolate active: atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin))   excipient: calcium carbonate colloidal silicon dioxide crospovidone hyprolose lactose monohydrate magnesium stearate opadry green 06o21881 polysorbate 80 pregelatinised maize starch active: ramipril 10mg   excipient: hypromellose microcrystalline cellulose opadry yellow sodium stearyl fumarate starch black ink (trinomia) gelatin iron oxide red titanium dioxide - trinomia is indicated for the secondary prevention of cardiovascular accidents as substitution therapy in adult patients adequately controlled with the mono-components given concomitantly at equivalent therapeutical doses

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

te arai biofarma limited - aspirin 100mg (2 x 50mg);  ; atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin));  ; ramipril 2.5mg;   - combination capsule - 100mg/20mg/2.5mg - active: aspirin 100mg (2 x 50mg)   excipient: microcrystalline cellulose opadry white oy-b-28920 amb purified talc sodium starch glycolate active: atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin))   excipient: calcium carbonate colloidal silicon dioxide crospovidone hyprolose lactose monohydrate magnesium stearate opadry green 06o21881 polysorbate 80 pregelatinised maize starch active: ramipril 2.5mg   excipient: hypromellose microcrystalline cellulose opadry yellow 80w32039 sodium stearyl fumarate starch black ink (trinomia) gelatin iron oxide black titanium dioxide - trinomia is indicated for the secondary prevention of cardiovascular accidents as substitution therapy in adult patients adequately controlled with the mono-components given concomitantly at equivalent therapeutical doses

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

te arai biofarma limited - aspirin 100mg (2 x 50mg);  ; atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin));  ; ramipril 5mg;   - combination capsule - 100mg/20mg/5mg - active: aspirin 100mg (2 x 50mg)   excipient: microcrystalline cellulose opadry white oy-b-28920 amb purified talc sodium starch glycolate active: atorvastatin calcium trihydrate 21.69mg (2 x 10.845mg (equivalent to 20mg atorvastatin))   excipient: calcium carbonate colloidal silicon dioxide crospovidone hyprolose lactose monohydrate magnesium stearate opadry green 06o21881 polysorbate 80 pregelatinised maize starch active: ramipril 5mg   excipient: hypromellose microcrystalline cellulose opadry yellow sodium stearyl fumarate starch black ink (trinomia) gelatin iron oxide black iron oxide red titanium dioxide - trinomia is indicated for the secondary prevention of cardiovascular accidents as substitution therapy in adult patients adequately controlled with the mono-components given concomitantly at equivalent therapeutical doses

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - sucroferric oxyhydroxide, quantity: 2500 mg - tablet, chewable - excipient ingredients: colloidal anhydrous silica; neohesperidin-dihydrochalcone; magnesium stearate; flavour - velphoro is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease (ckd) on dialysis.